logo
ProjectSigned

ONCOPEPTIDES (EGFF)

One of 4,332 projects Taiyo tracks in Sweden.

Source: European Investment Bank (EIB)

Quasi equity financing to Oncopeptides - a publicly listed Swedish biotech developing targeted therapies for difficult-to-treat haematological diseases such as Relapsed and Refractory Multiple Myeloma.

Status
Under Construction
Sector
Government
Location
Sweden
Updated
22 Jul 2026
Source
European Investment Bank (EIB)

ConstructChat

Ask ConstructChat about ONCOPEPTIDES (EGFF)

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “ONCOPEPTIDES (EGFF)” is an infrastructure initiative in the Government sector, located in Sweden. Taiyo aggregates data on it from European Investment Bank (EIB).

Participants

Sponsoring Agency

Status

Original status

signed

Taiyo status

Under Construction

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Quasi equity financing to Oncopeptides - a publicly listed Swedish biotech developing targeted therapies for difficult-to-treat haematological diseases such as Relapsed and Refractory Multiple Myeloma.

Original sector

Services

Location

Country

Sweden

Source

Source

European Investment Bank (EIB)

URL

More Details

Record type

Project

Sector

Government

Article published date

2026-02-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project